Despite years of congressional hearings, lawsuits, academic research, whistleblowers and testimony from parents and teenagers about the dangers of Instagram, Meta’s wildly popular app has failed to ...

Despite years of congressional hearings, lawsuits, academic research, whistleblowers and testimony from parents and teenagers about the dangers of Instagram, Meta’s wildly popular app has failed to ...

President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. announced Monday what they called “historic steps” in a plan to fight the growth of autism across America. Trump ...

The Trump administration is sharply expanding its use of artificial intelligence in immigration enforcement, using technology not just to track migrants but also to help determine who gets targeted ...

Despite this year’s new iPhones only barely hitting store shelves, new information about next year’s iPhone lineup is already brewing. Bloomberg’s Mark Gurman today shared some new details about the ...

The U.S. Department of Education announced a partnership Wednesday with more than 40 conservative organizations to create programming around civics aimed at the celebration of the 250th anniversary of ...

On Friday, CBC News reported that a major education reform document prepared for the Canadian province of Newfoundland and Labrador contains at least 15 fabricated citations that academics suspect ...

hrive Capital’s Josh Kushner has emerged as one of the most active investors in artificial intelligence, making billion-dollar bets on startups like OpenAI, Databricks and Anduril. Now his brother, ...

The co-founders who sold their last startup Anchor to Spotify are launching their next project: Oboe, an AI-powered educational app that enables anyone to create lightweight, flexible learning courses ...

Jyoti Madhusoodanan is a science writer in Portland, Oregon. Rafaella Rogatto De Faria was nearing the end of her PhD when her adviser proposed a fresh project. The idea was to analyse genetic, ...

An international multidisciplinary team has demonstrated for the first time that CRISPR-based gene activation (CRISPRa) can be used to treat genetic heart disease in vivo. The study, published in the ...